$MMATQ
META MATERIALS INC.

2023 Q3 Form 10-Q Financial Statement

#000095017023040676 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $2.200M $2.031M $3.324M
YoY Change -10.42% -38.91% 172.3%
Cost Of Revenue $790.0K $773.0K $878.0K
YoY Change 13.39% -11.96% 78994.59%
Gross Profit $1.406M $1.258M $2.446M
YoY Change -20.05% -48.58% 100.55%
Gross Profit Margin 63.93% 61.93% 73.59%
Selling, General & Admin $6.717M $6.694M $15.60M
YoY Change -62.06% -57.08% 118.58%
% of Gross Profit 477.58% 532.27% 637.71%
Research & Development $5.089M $5.060M $6.491M
YoY Change -18.37% -22.05% 90.18%
% of Gross Profit 361.8% 402.34% 265.39%
Depreciation & Amortization $1.700M $1.600M $1.821M
YoY Change 70.0% -12.15% 55.2%
% of Gross Profit 120.87% 127.23% 74.46%
Operating Expenses $16.33M $295.9M $22.09M
YoY Change -31.76% 1239.87% 109.39%
Operating Profit -$14.93M -$294.7M -$19.64M
YoY Change -32.68% 1400.3% 110.55%
Interest Expense $125.5K $4.522K -$1.114M
YoY Change -6.5% -100.41% -7.89%
% of Operating Profit
Other Income/Expense, Net $5.651M $417.7K -$337.0K
YoY Change -341.9% -223.96% -136.09%
Pretax Income -$9.278M -$294.3M -$21.09M
YoY Change -62.15% 1295.13% -57.94%
Income Tax $540.8K -$618.1K -$110.0K
% Of Pretax Income
Net Earnings -$8.737M -$293.7M -$20.98M
YoY Change -64.3% 1299.5% 256.65%
Net Earnings / Revenue -397.11% -14461.95% -631.3%
Basic Earnings Per Share -$0.02 -$0.65 -$0.07
Diluted Earnings Per Share -$0.02 -$0.65 -$69.60K
COMMON SHARES
Basic Shares Outstanding 477.3M 467.2M 296.6M
Diluted Shares Outstanding 477.8M 452.8M 301.5M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.200M $13.96M $54.83M
YoY Change -71.06% -74.55% -64.54%
Cash & Equivalents $9.190M $13.96M $54.04M
Short-Term Investments $1.254M
Other Short-Term Assets $808.0K $544.4K $76.28M
YoY Change -98.97% -99.29% 1.85%
Inventory $122.3K $477.2K $294.9K
Prepaid Expenses $2.119M $1.352M
Receivables $1.700M $1.251M $1.704M
Other Receivables $8.501K $8.722K $48.88K
Total Short-Term Assets $15.99M $19.83M $133.2M
YoY Change -85.81% -85.1% -42.24%
LONG-TERM ASSETS
Property, Plant & Equipment $46.02M $47.68M $39.55M
YoY Change 33.25% 20.57% 372.11%
Goodwill
YoY Change
Intangibles $51.26M $53.91M
YoY Change 0.45%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $105.8M $109.0M $375.2M
YoY Change -71.41% -70.94% 62.87%
TOTAL ASSETS
Total Short-Term Assets $15.99M $19.83M $133.2M
Total Long-Term Assets $105.8M $109.0M $375.2M
Total Assets $121.8M $128.9M $508.4M
YoY Change -74.77% -74.65% 10.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.70M $11.66M $11.45M
YoY Change -16.52% 1.84% 113.01%
Accrued Expenses $2.100M $2.002M $836.7K
YoY Change 142.91% 139.26% 199.0%
Deferred Revenue $1.481M $743.3K
YoY Change 137.46%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $709.0K $547.3K $976.4K
YoY Change -4.55% -43.94% -27.64%
Total Short-Term Liabilities $16.71M $16.76M $86.50M
YoY Change -80.91% -80.62% -0.87%
LONG-TERM LIABILITIES
Long-Term Debt $2.948M $3.181M $2.542M
YoY Change 37.9% 25.15% -29.38%
Other Long-Term Liabilities $6.900M $6.171M $4.000M
YoY Change 87.42% 54.29% 110.14%
Total Long-Term Liabilities $2.948M $3.181M $6.542M
YoY Change 37.9% -51.37% 18.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.71M $16.76M $86.50M
Total Long-Term Liabilities $2.948M $3.181M $6.542M
Total Liabilities $28.42M $28.61M $93.25M
YoY Change -69.71% -69.32% 0.29%
SHAREHOLDERS EQUITY
Retained Earnings -$530.6M -$521.8M
YoY Change 175.94%
Common Stock $628.5M $626.6M
YoY Change 6.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $93.33M $100.2M $415.1M
YoY Change
Total Liabilities & Shareholders Equity $121.8M $128.9M $508.4M
YoY Change -74.77% -74.65% 10.3%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$8.737M -$293.7M -$20.98M
YoY Change -64.3% 1299.5% 256.65%
Depreciation, Depletion And Amortization $1.700M $1.600M $1.821M
YoY Change 70.0% -12.15% 55.2%
Cash From Operating Activities -$11.20M -$10.37M -$10.26M
YoY Change -42.6% 1.04% 395.29%
INVESTING ACTIVITIES
Capital Expenditures $1.470M $4.801M -$7.224M
YoY Change -148.94% -166.45% 164.11%
Acquisitions
YoY Change
Other Investing Activities $6.080M $0.00 -$4.712M
YoY Change -100.0% -103.0%
Cash From Investing Activities $4.620M -$4.801M -$11.94M
YoY Change -253.81% -59.78% -107.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.510M 22.85M 46.34M
YoY Change -1092.09% -50.68% -493.85%
NET CHANGE
Cash From Operating Activities -11.20M -10.37M -10.26M
Cash From Investing Activities 4.620M -4.801M -11.94M
Cash From Financing Activities 2.510M 22.85M 46.34M
Net Change In Cash -4.070M 7.688M 24.14M
YoY Change -82.13% -68.15% -82.82%
FREE CASH FLOW
Cash From Operating Activities -$11.20M -$10.37M -$10.26M
Capital Expenditures $1.470M $4.801M -$7.224M
Free Cash Flow -$12.67M -$15.17M -$3.034M
YoY Change -23.26% 399.91% -556.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001431959
CY2023Q2 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36247
dei Entity Registrant Name
EntityRegistrantName
Meta Materials Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-3237581
dei Entity Address Address Line1
EntityAddressAddressLine1
60 Highfield Park Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Dartmouth
dei Entity Address State Or Province
EntityAddressStateOrProvince
NS
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
B3A 4R9
dei City Area Code
CityAreaCode
902
dei Local Phone Number
LocalPhoneNumber
482-5729
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MMAT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
477261145
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13955519
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10090858
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
514350
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1720613
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1251004
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
902718
CY2023Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
333300
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2211900
CY2023Q2 us-gaap Inventory Net
InventoryNet
477197
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3294151
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8722
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8461
CY2023Q2 us-gaap Assets Current
AssetsCurrent
19834243
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22604676
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
53906464
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56313317
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47680219
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7437981
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5576824
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
CY2023Q2 us-gaap Assets
Assets
128858907
CY2022Q4 us-gaap Assets
Assets
408917982
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11664885
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16694211
CY2023Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
942770
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
547336
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
743255
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
730501
CY2023Q2 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
825132
mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
1407533
CY2022Q4 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
799490
CY2023Q2 mmat Funding Obligation Current
FundingObligationCurrent
981873
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1059105
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
967126
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16764356
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19674554
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
467405
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
479808
CY2023Q2 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
394945
CY2022Q4 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
319017
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2491922
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3253985
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5309123
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3375031
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
180705
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3181271
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2023Q2 us-gaap Liabilities
Liabilities
28609022
CY2022Q4 us-gaap Liabilities
Liabilities
30353829
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
471881955
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
471881955
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
362247867
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
362247867
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
450059
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
340425
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
626124206
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
590962866
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4480988
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5242810
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-521843392
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-207496328
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
100249885
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128858907
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
408917982
CY2023Q2 us-gaap Revenues
Revenues
2030524
CY2022Q2 us-gaap Revenues
Revenues
3323727
us-gaap Revenues
Revenues
3442783
us-gaap Revenues
Revenues
6298422
CY2023Q2 mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
758618
CY2022Q2 mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
701283
mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
1345646
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
301488660
CY2023Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
17296
CY2022Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
18850
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
27343
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
40659
CY2023Q2 mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
-2936
CY2022Q2 mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
157818
mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
140969
mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
208471
CY2023Q2 us-gaap Gross Profit
GrossProfit
1257546
CY2022Q2 us-gaap Gross Profit
GrossProfit
2445776
us-gaap Gross Profit
GrossProfit
1928825
us-gaap Gross Profit
GrossProfit
4641759
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
780233
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
951750
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3087586
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1967850
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5913267
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11300296
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12682706
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21202836
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5059614
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4118781
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10120370
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7208206
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3358527
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1801319
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6593022
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3453504
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-2807086
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3915612
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-948647
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7860400
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
1469149
us-gaap Restructuring Charges
RestructuringCharges
1469149
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282173053
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282173053
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
295946757
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
22087758
us-gaap Operating Expenses
OperatingExpenses
315177239
us-gaap Operating Expenses
OperatingExpenses
41692796
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-294689211
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19641982
us-gaap Operating Income Loss
OperatingIncomeLoss
-313248414
us-gaap Operating Income Loss
OperatingIncomeLoss
-37051037
CY2023Q2 us-gaap Interest Expense
InterestExpense
4522
CY2022Q2 us-gaap Interest Expense
InterestExpense
142055
us-gaap Interest Expense
InterestExpense
117520
us-gaap Interest Expense
InterestExpense
306489
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1162273
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-971713
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1447184
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-823322
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-740005
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-336993
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1318125
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1346436
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
417746
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1450761
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11539
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2476247
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-294271465
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21092743
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-313236875
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39527284
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-618079
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-109985
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-914811
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-109985
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-293653386
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-20982758
us-gaap Net Income Loss
NetIncomeLoss
-312322064
us-gaap Net Income Loss
NetIncomeLoss
-39417299
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
439035
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3056676
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
761822
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2151294
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
439035
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3056676
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
761822
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2151294
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-293214351
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24039434
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-311560242
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41568593
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
452837999
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
452837999
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301488660
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
411090600
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
411090600
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
293481943
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293481943
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
372970132
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-293653386
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
439035
CY2023Q2 mmat Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
25847738
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2883446
CY2023Q2 mmat Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
285
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2470473
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
100249885
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
321737682
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-20982758
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3056676
CY2022Q2 mmat Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
50000000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3680666
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
108152
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
67122511
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3876887
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
415125132
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
us-gaap Net Income Loss
NetIncomeLoss
-312322064
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
761822
mmat Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
36324808
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3322231
mmat Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
711531
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-468134
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
100249885
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334708115
us-gaap Net Income Loss
NetIncomeLoss
-39417299
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2151294
mmat Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
50000000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3680666
mmat Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
474894
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
67122511
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8068871
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
415125132
us-gaap Net Income Loss
NetIncomeLoss
-312322064
us-gaap Net Income Loss
NetIncomeLoss
-39417299
mmat Noncash Finance Income Expense
NoncashFinanceIncomeExpense
-740777
mmat Noncash Finance Income Expense
NoncashFinanceIncomeExpense
12920
us-gaap Paid In Kind Interest
PaidInKindInterest
147545
us-gaap Paid In Kind Interest
PaidInKindInterest
273554
mmat Non Cash Interest Income
NonCashInterestIncome
822898
mmat Non Cash Lease Expense
NonCashLeaseExpense
831505
mmat Non Cash Lease Expense
NonCashLeaseExpense
488299
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282173053
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-914811
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-109985
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6620365
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3494163
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-18843
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1701498
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
1674111
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-913101
mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
-23006
mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
-165466
mmat Government Assistance
GovernmentAssistance
3047
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
783
us-gaap Share Based Compensation
ShareBasedCompensation
-807678
us-gaap Share Based Compensation
ShareBasedCompensation
7623207
mmat Non Cash Consulting Expense
NonCashConsultingExpense
445664
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
1554391
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
2531889
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25885373
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29003401
mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
6494362
mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
8971435
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
39140
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1620281
mmat Proceeds From Below Market Capital Government Loan
ProceedsFromBelowMarketCapitalGovernmentLoan
256240
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3486906
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5238122
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10798920
mmat Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
36324808
mmat Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
50000000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3322231
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3680666
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
195780
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
182295
mmat Proceeds From Stock Option And Warrants Exercises
ProceedsFromStockOptionAndWarrantsExercises
711531
mmat Proceeds From Stock Option And Warrants Exercises
ProceedsFromStockOptionAndWarrantsExercises
474894
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33518328
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46611933
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2394833
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6809612
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11811471
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47434472
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
263565
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-203738
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14469869
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54040346
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1550901
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1604903
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2225962
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
142378
mmat Number Of Active Patent Documents
NumberOfActivePatentDocuments
500
mmat Number Of Patents Have Issued
NumberOfPatentsHaveIssued
300
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reclassification of Prior Year Presentation</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the condensed consolidated interim statement of operations and comprehensive loss.</span></p>
us-gaap Substantial Doubt About Going Concern Managements Evaluation
SubstantialDoubtAboutGoingConcernManagementsEvaluation
Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances.
us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
us-gaap Net Income Loss
NetIncomeLoss
-312300000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282200000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
79100000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-521800000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
499387
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
490077
CY2023Q2 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
11373
CY2022Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
11345
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51006
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51589
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
45390
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42058
CY2023Q2 mmat Inventory Provision
InventoryProvision
129959
CY2022Q4 mmat Inventory Provision
InventoryProvision
127042
CY2023Q2 us-gaap Inventory Net
InventoryNet
477197
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1351938
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2835660
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
544425
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
365583
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1397788
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4000856
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3294151
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
61244750
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52954295
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13564531
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10279596
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47680219
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2023Q2 us-gaap Depreciation
Depreciation
1600000
CY2022Q2 us-gaap Depreciation
Depreciation
800000
us-gaap Depreciation
Depreciation
3100000
us-gaap Depreciation
Depreciation
1600000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
67230888
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
65811004
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13324424
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9497687
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
53906464
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56313317
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3500000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
424587
mmat Goodwill Impairment
GoodwillImpairment
282173053
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282200000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
3728607
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3553955
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
547336
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3181271
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
mmat Event Market Price Description
EventMarketPriceDescription
“Event Market Price” means, with respect to any Share Combination Event Date, the quotient determined by dividing (x) the sum of the volume weighted average price of the shares of common stock for each of the five trading days following such Share Combination Event divided by (y) five.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8456
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0357
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y5M23D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.8
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M21D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17611251
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1519336
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1250675
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.84
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2635161
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.27
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31228544
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.82
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M9D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
109875
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
25774708
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
100875
CY2023Q2 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
31228544
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
25774708
CY2022Q4 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24327577
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.19
CY2023Q2 mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
600000
CY2022Q2 mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
100000
mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
900000
mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
100000
CY2023Q2 mmat Net Loss
NetLoss
-293653386
CY2022Q2 mmat Net Loss
NetLoss
-20982758
mmat Net Loss
NetLoss
-312322064
mmat Net Loss
NetLoss
-39417299
CY2023Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
2025000
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
2025000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-295678386
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20982758
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-314347064
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39417299
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
452837999
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301488660
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
411090600
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293481943
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
452837999
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
301488660
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
411090600
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
293481943
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
163605650
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81625589
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
163605650
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81625589
mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
0
mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-125558
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1533
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34752
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
332424
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
67162
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3995939
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
685141
mmat Increase Decrease In Trade Payables And Accruals
IncreaseDecreaseInTradePayablesAndAccruals
-5522384
mmat Increase Decrease In Trade Payables And Accruals
IncreaseDecreaseInTradePayablesAndAccruals
-1603016
us-gaap Restructuring Costs
RestructuringCosts
942770
us-gaap Restructuring Costs
RestructuringCosts
0
mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
261
mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
108102
mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0
mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
231
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-639564
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-159043
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
1554391
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
2531889
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2030524
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3323727
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3442783
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6298422
CY2021Q4 mmat Development Contract Value
DevelopmentContractValue
41500000
CY2021 mmat Development Contract Period Maximum
DevelopmentContractPeriodMaximum
P5Y
CY2022Q4 mmat Development Contract Value
DevelopmentContractValue
4300000
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
469369
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
443263
us-gaap Operating Lease Expense
OperatingLeaseExpense
869819
us-gaap Operating Lease Expense
OperatingLeaseExpense
885720
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
148523
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
77603
us-gaap Short Term Lease Cost
ShortTermLeaseCost
228086
us-gaap Short Term Lease Cost
ShortTermLeaseCost
159240
CY2023Q2 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
135630
CY2022Q2 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
55525
mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
225759
mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
114342
CY2023Q2 us-gaap Lease Cost
LeaseCost
753522
CY2022Q2 us-gaap Lease Cost
LeaseCost
576391
us-gaap Lease Cost
LeaseCost
1323664
us-gaap Lease Cost
LeaseCost
1159302
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
633875
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1468819
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1493735
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1351197
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
932629
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
940836
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3819652
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10640743
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4272515
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
6368228
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1059105
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5309123
us-gaap Restructuring And Related Activities Initiation Date
RestructuringAndRelatedActivitiesInitiationDate
2023-06-06
CY2023Q2 mmat Provision For Severance Cost
ProvisionForSeveranceCost
900000
mmat Estimated Realignment And Consolidation Charges
EstimatedRealignmentAndConsolidationCharges
2600000
us-gaap Severance Costs1
SeveranceCosts1
1500000
us-gaap Payments For Restructuring
PaymentsForRestructuring
500000
mmat Number Of Patents
NumberOfPatents
6
us-gaap Royalty Expense
RoyaltyExpense
0
us-gaap Royalty Expense
RoyaltyExpense
0
CY2022Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
12655
CY2023Q2 mmat Annual Lease Payments Per Square Foot In Lease Year One
AnnualLeasePaymentsPerSquareFootInLeaseYearOne
18
CY2023Q2 mmat Annual Lease Payments Per Square Foot In Lease Year Two
AnnualLeasePaymentsPerSquareFootInLeaseYearTwo
18.5
CY2023Q2 mmat Annual Lease Payments Per Square Foot In Lease Year Three
AnnualLeasePaymentsPerSquareFootInLeaseYearThree
19
CY2023Q2 mmat Annual Lease Payments Per Square Foot In Lease Year Four
AnnualLeasePaymentsPerSquareFootInLeaseYearFour
19.5
CY2023Q2 mmat Annual Lease Payments Per Square Foot In Lease Year Five
AnnualLeasePaymentsPerSquareFootInLeaseYearFive
20

Files In Submission

Name View Source Status
0000950170-23-040676-index-headers.html Edgar Link pending
0000950170-23-040676-index.html Edgar Link pending
0000950170-23-040676.txt Edgar Link pending
0000950170-23-040676-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img164448760_0.jpg Edgar Link pending
img165372281_0.jpg Edgar Link pending
img65777253_0.jpg Edgar Link pending
img66700774_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
mmat-20230630.htm Edgar Link pending
mmat-20230630.xsd Edgar Link pending
mmat-ex10_10.htm Edgar Link pending
mmat-ex10_11.htm Edgar Link pending
mmat-ex10_6.htm Edgar Link pending
mmat-ex10_7.htm Edgar Link pending
mmat-ex10_8.htm Edgar Link pending
mmat-ex10_9.htm Edgar Link pending
mmat-ex31_1.htm Edgar Link pending
mmat-ex31_2.htm Edgar Link pending
mmat-ex32_1.htm Edgar Link pending
mmat-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
mmat-20230630_def.xml Edgar Link unprocessable
mmat-20230630_lab.xml Edgar Link unprocessable
mmat-20230630_pre.xml Edgar Link unprocessable
mmat-20230630_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mmat-20230630_cal.xml Edgar Link unprocessable